🇨🇦 Batroxobin combined with low molecular weight heparin in Canada

Batroxobin combined with low molecular weight heparin (Batroxobin combined with low molecular weight heparin) regulatory status in Canada.

Marketing authorisation

Batroxobin combined with low molecular weight heparin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Batroxobin combined with low molecular weight heparin approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Batroxobin combined with low molecular weight heparin in Canada?

Capital Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.